PH30882A - Activated Rnase L as a maker for viral infections. - Google Patents

Activated Rnase L as a maker for viral infections.

Info

Publication number
PH30882A
PH30882A PH36550A PH36550A PH30882A PH 30882 A PH30882 A PH 30882A PH 36550 A PH36550 A PH 36550A PH 36550 A PH36550 A PH 36550A PH 30882 A PH30882 A PH 30882A
Authority
PH
Philippines
Prior art keywords
pathway
rnase
aids
biochemical
inhibitor
Prior art date
Application number
PH36550A
Other languages
English (en)
Inventor
Carter De William
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of PH30882A publication Critical patent/PH30882A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/702Specific hybridization probes for retroviruses
    • C12Q1/703Viruses associated with AIDS
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16HIV-1, HIV-2
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/922Ribonucleases (RNAses); Deoxyribonucleases (DNAses)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PH36550A 1987-03-03 1988-02-24 Activated Rnase L as a maker for viral infections. PH30882A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2137287A 1987-03-03 1987-03-03

Publications (1)

Publication Number Publication Date
PH30882A true PH30882A (en) 1997-12-23

Family

ID=21803819

Family Applications (1)

Application Number Title Priority Date Filing Date
PH36550A PH30882A (en) 1987-03-03 1988-02-24 Activated Rnase L as a maker for viral infections.

Country Status (20)

Country Link
EP (1) EP0285263B1 (fi)
JP (1) JPH0675520B2 (fi)
KR (1) KR880011593A (fi)
AT (1) ATE107964T1 (fi)
AU (1) AU618525B2 (fi)
CA (1) CA1337278C (fi)
DE (1) DE3850428T2 (fi)
DK (1) DK112888A (fi)
ES (1) ES2058252T3 (fi)
FI (1) FI880959A (fi)
IE (1) IE66831B1 (fi)
IL (1) IL85576A0 (fi)
MX (1) MX173802B (fi)
NO (1) NO880934L (fi)
NZ (1) NZ223721A (fi)
OA (1) OA08720A (fi)
PH (1) PH30882A (fi)
PT (1) PT86878B (fi)
RU (1) RU2049336C1 (fi)
ZA (1) ZA881471B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593973A (en) * 1987-09-04 1997-01-14 Hemispherx Biopharma Inc. Treatment of viral hepatitis with mismatched dsRNA
DE3853755T2 (de) * 1987-09-04 1995-12-14 Hem Pharma Corp Diagnose von Mangelzuständen doppelsträngiger RNS.
AU724056B2 (en) * 1987-09-04 2000-09-14 Hem Research, Inc. Diagnosis and treatment of double stranded deficiency states
ATE103493T1 (de) * 1988-07-07 1994-04-15 Hem Pharma Corp Diagnose und behandlung chronischer ermuedungserscheinungen.
US5985565A (en) * 1996-10-09 1999-11-16 Temple University-Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
US6207366B1 (en) 1999-04-14 2001-03-27 Temple University- Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
US6080554A (en) * 1999-04-27 2000-06-27 R.E.D. Laboratories, N.V. Methods and compositions for use in characterizing multiple sclerosis disease activity in a subject
WO2017193051A1 (en) * 2016-05-06 2017-11-09 The Trustees Of Princeton University Methods of monitoring rnase l activity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3380200D1 (en) * 1982-09-16 1989-08-24 William Alvin Carter Anti-proliferative action of dsnras on tumor cells
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)

Also Published As

Publication number Publication date
IE880587L (en) 1988-09-03
DK112888D0 (da) 1988-03-02
DE3850428T2 (de) 1994-11-24
PT86878B (pt) 1992-05-29
PT86878A (pt) 1988-04-01
NO880934L (no) 1988-09-05
IL85576A0 (en) 1988-08-31
CA1337278C (en) 1995-10-10
AU618525B2 (en) 1992-01-02
ATE107964T1 (de) 1994-07-15
NZ223721A (en) 1991-02-26
EP0285263A2 (en) 1988-10-05
OA08720A (en) 1989-03-31
DK112888A (da) 1988-09-04
EP0285263B1 (en) 1994-06-29
JPH0675520B2 (ja) 1994-09-28
NO880934D0 (no) 1988-03-02
AU1256388A (en) 1988-09-01
RU2049336C1 (ru) 1995-11-27
JPS63309200A (ja) 1988-12-16
FI880959A0 (fi) 1988-03-02
DE3850428D1 (de) 1994-08-04
ES2058252T3 (es) 1994-11-01
EP0285263A3 (en) 1990-04-18
ZA881471B (en) 1988-12-28
KR880011593A (ko) 1988-10-29
MX173802B (es) 1994-03-29
IE66831B1 (en) 1996-02-07
FI880959A (fi) 1988-09-04

Similar Documents

Publication Publication Date Title
AU6497694A (en) Method for selective inactivation of viral replication
PH30882A (en) Activated Rnase L as a maker for viral infections.
NZ228645A (en) 1,3-dioxolane derivatives substituted in the 5th position by a purine or pyrimidine radical; treatment of viral infections
TR199901530T2 (xx) HIV ve kanser tedavisi.
DK449888A (da) Anvendelse af dsrna til fremstilling af et parenteralt laegemiddel der forstaerker immunforsvaret
AU590817B2 (en) Antiviral combinations
SE8601435D0 (sv) Aktivt pansar
EP0135713A3 (en) Antiviral combinations
TW366339B (en) Derivatives of benzimidazolyl-cyclopentanediol, -cyclopentanol and -cyclopentenol, and pharmaceutical composition containing the same
CA2478527A1 (en) Arrangement for supporting a mortar shell into barrel of weapon and a method for attaching a support member to a mortar shell
IL85603A0 (en) Synergistic interplay of lymphokines and double-stranded rnas
MY106304A (en) Antiviral combinations and compounds therefor.
DK615788A (da) Nucleosidforbindelser til anvendelse mod virale infektioner
AU2353988A (en) Gold-bearing pyrrhotite, arsenopyrite recovery by flotation
EP0340778A3 (en) Prodrugs of 2',3'- didehydro-2',3'-dideoxynucleosides
EP0335770A3 (en) Novel fluorophosphonate nucleotide derivatives
DE60128565D1 (en) Polycyclische xanthone als antibiotika
WO1988007080A3 (en) Transgenic animal cells resistant to viral infection
SE8702004D0 (sv) Rotasjonsprosjektil med et hult neseparti
JPS6431805A (en) Elimination of acrylonitrile in water or aqueous dispersion
Heidemann Ecological problems of the seal populations.).
JPS5539847A (en) Bumper
ES2007988A6 (es) Procedimiento de obtencion de un derivado de guanina.
TH10132A (th) การยับยั้งไวรัสที่ทำให้เกิดภูมิคุ้มกันบกพร่องในคน (hiv) โดยการทำงานร่วมกันแบบเสริมของอนุพันธุ์นิวคลีโอไซด์